Europe’s First Execution-Led Venture Capital Focused on Women’s Health
Europe’s first venture fund dedicated exclusively to women’s health innovation across the full spectrum of women’s lives. WHIF invests in breakthrough solutions shaping the future of women’s health
About
- WHIF (Women’s Health Impact Fund) is a €50M execution-first venture capital fund dedicated to advancing women’s health innovations across Europe.
- Our mission is to drive measurable outcomes by investing in innovative, scalable solutions that significantly improve women’s health.
- We partner with pioneering founders to solve critical women’s health challenges with strategic capital and operational guidance.
Investment Thesis
Focused on Results-Driven Innovations
50%
of the
Population
<6%
of healthcare
VC Funding
€1T+
Femtech
Opportunity
90%
Lack
Specialized Capital
50%
of the
Population
<6%
of healthcare
VC Funding
€1T+
Femtech
Opportunity
90%
Lack
Specialized Capital
50%
of the
Population
<6%
of healthcare
VC Funding
€1T+
Femtech
Opportunity
90%
Lack
Specialized Capital
Investment Focus
WHIF invests across high-growth verticals within women’s health, targeting scalable platforms positioned for international expansion.
Reproductive Health
Fertility technologies, reproductive diagnostics, assisted reproduction innovation.
Menopause & Midlife Health
Hormonal health platforms, metabolic solutions, longevity-focused technologies.
Maternal Health
Pregnancy monitoring, remote diagnostics, postnatal care innovation.
Digital Therapeutics & AI
Data-driven clinical platforms, AI-enabled care models, precision health systems.
Women's Oncology
Gender specific diagnostics, early detection, technologies, therapeutic innovation.
Mental Health & Neuroendocrine
Pregnancy monitoring, remote diagnostics, postnatal care innovation.
Longevity & Healthy Aging
Prevention, healthspan optimization, aging biology
Investment Focus
WHIF invests across high-growth verticals within women’s health, targeting scalable platforms positioned for international expansion.
Reproductive Health
Fertility technologies, reproductive diagnostics, assisted reproduction innovation.
Menopause & Midlife Health
Hormonal health platforms, metabolic solutions, longevity-focused technologies.
Maternal Health
Pregnancy monitoring, remote diagnostics, postnatal care innovation.
Digital Therapeutics & AI
Data-driven clinical platforms, AI-enabled care models, precision health systems.
Women's Oncology
Gender specific diagnostics, early detection, technologies, therapeutic innovation.
Mental Health & Neuroendocrine
Pregnancy monitoring, remote diagnostics, postnatal care innovation.
Longevity & Healthy Aging
Prevention, healthspan optimization, aging biology
Investment Focus
WHIF invests across high-growth verticals within women’s health, targeting scalable platforms positioned for international expansion.
Reproductive Health
Fertility technologies, reproductive diagnostics, assisted reproduction innovation.
Menopause & Midlife Health
Hormonal health platforms, metabolic solutions, longevity-focused technologies.
Maternal Health
Pregnancy monitoring, remote diagnostics, postnatal care innovation.
Digital Therapeutics & AI
Data-driven clinical platforms, AI-enabled care models, precision health systems.
Women's Oncology
Gender specific diagnostics, early detection, technologies, therapeutic innovation.
Mental Health & Neuroendocrine
Pregnancy monitoring, remote diagnostics, postnatal care innovation.
Longevity & Healthy Aging
Prevention, healthspan optimization, aging biology
Why WHIF Matters Today.
WHIF was created to address this gap before it became a trend. Pre-Launched ahead of the mainstream shift in 2025, WHIF is built as a next-generation venture platform designed to deliver both competitive financial returns and measurable societal impact.
By investing early in breakthrough women’s health solutions, WHIF aims to:
- Unlock undercapitalized innovation
- Improve health outcomes at scale
- Generate durable long-term value
WHIF operates at the intersection of capital, science, and impact, aligning investor performance with real-world progress in women’s health. This is where financial returns and societal impact converge.
Women's Health Deserves More Investment — And It's Largely Untapped.
Women make up nearly half of the global population, yet only a small fraction of private healthcare investment targets women’s health. Many conditions that uniquely affect women — from menopause to cardiovascular disease — remain under-addressed, leaving both unmet needs and economic opportunity on the table.
A Trillion-Dollar Opportunity in Women's Health, Starting in Southern Europe.
Southern Europe offers a unique combination of scientific talent, innovative startups, and untapped markets. By backing women’s health innovations here, WHIF helps unlock solutions that can scale across Europe and globally, while improving outcomes and creating measurable impact.
Women's Health Impact Fund (WHIF) — Setting the Standard.
WHIF is a purpose-built venture fund supporting startups that improve women’s health. We partner with innovators to scale evidence-based solutions from Southern Europe to the world — creating a new standard for women’s health investment.
WEF just visualized a hard truth
Women’s health has been systematically underfunded worldwide.
This is not a niche issue. It’s one of the largest untapped opportunities in global healthcare.
Women’s Health Impact Fund (WHIF) is being built as a direct response to this gap, with a 2025 Pre-launch—without waiting for policy, trends, or permission. Acting on the opportunity before the world catches up, we didn’t follow a trend, we are building the category.
We invest with an eye towards the future and partner with founders who are building what does not yet exist
Partnering with Founders to Scale Solutions from Southern Europe Globally.
WHIF supports portfolio companies with:
- Clinical and regulatory strategy
- Reimbursement and go-to-market support
- Cross-border European expansion
- Access to follow-on capital and global investors
- Strategic partnerships with hospitals, insurers, and industry
Impact Is Core — Not an Afterthought.
WHIF supports portfolio companies with:
- Improve women’s health outcomes and access to care
- Expand inclusion in clinical research and evidence generation
- Enhance affordability and healthcare system efficiency
- Support female leadership and workforce empowerment
- Track ESG-aligned metrics for LP reporting
Press & Recognition
Recognition and media coverage highlighting WHIF’s leadership in
women’s health innovation and femtech investment.
- WHIF Featured in National Media
Women’s Health Impact Fund Featured for shaping the future of women’s health investment and advancing next-generation femtech innovation across Europe.
- Global Industry Recognition
WHIF leadership recognized among the 200 Trailblazing Leaders in Health & FemTech by Women of Wearables for advancing the future of women’s health innovation.
